Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Trial details
- Registry ID
- NCT05054725
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as SAR442720
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard TherapiesNCT05054725 | RVMD | Phase 2 | Completed | 2024-07-03Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |